» Articles » PMID: 31447694

Deciphering the Mechanical Network of Chronic Atrophic Gastritis: A Urinary Time-Dependent Metabonomics-Based Network Pharmacology Study

Overview
Journal Front Physiol
Date 2019 Aug 27
PMID 31447694
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic atrophic gastritis (CAG) is one of the most important pre-cancerous states with a high prevalence. Deciphering its mechanical network is of significant importance for its diagnosis and treatment. The time-series factor associated with CAG progression specially needs to be considered together with its biological condition. In the present work, H NMR-based dynamic metabonomics was firstly performed to analyze the urinary metabolic features of CAG coupled with ANOVA-simultaneous component analysis (ASCA). As results, 4 (alanine, lipids, creatine, and dimethylglycine), 2 (α-ketoglutarate and alanine) and 5 (succinate, α-ketoglutarate, alanine, hippurate, and allantoin) urine metabolites were finally selected as the candidate biomarkers related to phenotype, time, and their interaction, respectively. Mechanistically, the network pharmacology analysis further revealed these metabolites were involved into mitochondrial function, oxidation reduction, cofactor binding, generation of precursor metabolites and energy, nucleotide binging, coenzyme metabolic process, cofactor metabolic process, cellular respiration, and tricarboxylic acid cycle. Especially, mitochondria were the most important targeted organelle referred 30 targeted proteins. The present work provided a novel network pharmacology approach for elucidating the mechanisms underlying the pathogenesis of CAG based on urinary time dependent metabonomics.

Citing Articles

Current study of pathogenetic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review.

Kuang W, Xu J, Xu F, Huang W, Majid M, Shi H Front Cell Dev Biol. 2024; 12:1513426.

PMID: 39720008 PMC: 11666564. DOI: 10.3389/fcell.2024.1513426.


Identification of the Biomarkers for Chronic Gastritis with TCM Damp Phlegm Pattern by Using Tongue Coating Metabolomics.

You Z, Zhang J, Xu Y, Lu J, Zhang R, Zhu Z J Inflamm Res. 2024; 17:8027-8045.

PMID: 39507266 PMC: 11539634. DOI: 10.2147/JIR.S480307.


Optimization of protein removal process of polysaccharide and its immunomodulatory mechanism in cyclophosphamide-induced mice by metabolomics and network pharmacology.

Ding J, Du H, Tan H, Li J, Wang L, Li L Food Sci Nutr. 2023; 11(1):364-378.

PMID: 36655085 PMC: 9834838. DOI: 10.1002/fsn3.3067.


Metabolite Characteristics in Tongue Coating from Damp Phlegm Pattern in Patients with Gastric Precancerous Lesion.

Xu Y, Zhang R, Morris R, Cheng F, Wang Y, Zhu Z Evid Based Complement Alternat Med. 2021; 2021:5515325.

PMID: 34122594 PMC: 8189775. DOI: 10.1155/2021/5515325.


Transcriptome Analysis of lncRNA-mRNA Interactions in Chronic Atrophic Gastritis.

Chao Y, Jin J, Wang L, Jin X, Yang L, Zhang B Front Genet. 2021; 11:612951.

PMID: 33505433 PMC: 7831747. DOI: 10.3389/fgene.2020.612951.

References
1.
Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham D . Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter. 2002; 6(4):294-9. DOI: 10.1046/j.1523-5378.2001.00042.x. View

2.
Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

3.
Smilde A, Jansen J, Hoefsloot H, Lamers R, van der Greef J, Timmerman M . ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data. Bioinformatics. 2005; 21(13):3043-8. DOI: 10.1093/bioinformatics/bti476. View

4.
Gruno M, Peet N, Seppet E, Kadaja L, Paju K, Eimre M . Oxidative phosphorylation and its coupling to mitochondrial creatine and adenylate kinases in human gastric mucosa. Am J Physiol Regul Integr Comp Physiol. 2006; 291(4):R936-46. DOI: 10.1152/ajpregu.00162.2006. View

5.
Weck M, Brenner H . Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev. 2006; 15(6):1083-94. DOI: 10.1158/1055-9965.EPI-05-0931. View